INTRODUCTION
Formation of the endocardial cushion involves endocardial-mesenchymal transformation as well as contributions from the cardiac neural crest. The primary source of mesenchyme in the atrioventricular (AV) canal in the mouse and chick embryo is thought to be endocardial cells (Bolender and Markwald, 1979; Markwald et al., 1979 Markwald et al., , 1977 . In the mouse, at embryonic day (E) 9 -9.5, the heart consists of two epithelial layers, the endocardium and the myocardium, which are separated by an acellular matrix (the cardiac jelly). Between E9.5 and E10.0, a subset of cardiac endothelial cells in the AV canal and outflow tract (OT) transforms from an epithelial to a mesenchymal morphology, migrates into the previously acellular cardiac jelly, and participates in the formation of the valves and membranous septa (Kaufman, 1992; Runyan and Markwald, 1983) . Neural crest cells do not appear to make a significant contribution to the AV canal, at least in the chick, based on studies which indicate that (1) neural crest cells have not yet migrated into the heart when the mesenchyme of the AV canal is developed (Noden et al., 1995) , and (2) AV septal defects are rarely seen after ablation of the premigratory cardiac neural crest (Nishibatake et al., 1987) . In contrast to mesenchyme in the AV canal, the origins of the mesenchyme in the OT are more controversial. Based on the experiments using chick-quail chimera embryos, the current belief is that two kinds of mesenchyme, cardiac neural crest-derived mesenchyme and non-neural crest-derived mesenchyme, play a role in outflow septation and remodeling. When the mesenchyme in the OT regions initially develops, nonneural crest cells are the primary source of the mesenchyme. In later stage embryos, in which the aorticopulmonary (AP) septation complex starts to develop, cardiac neural crest cells are the primary component of the mesenchyme in the septation complex. However, significant regions in the conotruncal ridges are composed of nonneural crest-derived mesenchyme (Waldo et al., 1998 (Waldo et al., , 1999 . The source of the nonneural crest-derived mesenchyme may be endocardial cells.
Study of the avian system has an advantage over the mammalian system because of the accessibility of developing embryos as well as availability of lineage-specific probes (Coffin and Poole, 1988; Crossin et al., 1986; Pardanaud et al., 1987; Wunsch et al., 1994) and chick-quail chimera (Le Douarin, 1982) . Although in vitro assays using mouse endocardial cushion explants can reveal molecular pathways involved in endocardial-mesenchymal transformation (Nakajima et al., 1997; Yamamura et al., 1997) , it is essential to investigate the formation of the endocardial cushion in vivo. For this purpose, it is highly useful to establish mouse models in which we can dissect molecular mechanisms underlying lineage establishment with the aid of lineage-specific promoters/enhancers.
The Cre/loxP system can be used for lineage analyses in the mouse. Cre is the bacteriophage P1-derived recombinase which efficiently excises DNA flanked by two directly repeated loxP recognition sites (Sauer and Henderson, 1988; Sternberg and Hamilton, 1981) . Temporal or spatial regulation of Cre-mediated recombination can be achieved by the use of tissue-specific and developmental stage-specific promoters, ligand-inducible promoters, or ligand-dependent Cre fusion proteins (Feil et al., 1996; Gu et al., 1994; Kü hn et al., 1995; Kulkarni et al., 1999) . Mice carrying reporter transgenes (e.g., lacZ) whose expression is controlled by a tissue-specific promoter will show the "current" expression of the transgene. In contrast, Cre-transgenic mice can be used to analyze the lineage history of the transgene expression when they also carry Cre-dependent reporter transgenes whose expression is activated only after Cremediated recombination (Araki et al., 1995; Soriano, 1999) .
Promoter and enhancer regions of the mouse Tie2 gene drive transgene expression specifically in endothelial cells (Schlaeger et al., 1997) . The Tie2 gene encodes an angiopoietin receptor, a member of the receptor tyrosine kinase family (Davis et al., 1996; Sato et al., 1993) . Tie2 expression is detected as the first endothelial cells arise, remains positive in endothelial cells throughout development, and is detectable in virtually all endothelial cells of adult tissues (Sato et al., 1993; Schnü rch and Risau, 1993; Wong et al., 1997) . Tie2-lacZ transgenic mice demonstrate a pan-endothelial-specific pattern of lacZ staining throughout embryogenesis and adulthood (Schlaeger et al., 1997) . Since this promoter/enhancer region of the mouse Tie2 gene has the capacity to drive pan-endothelial cell transgene expression, we generated Tie2-Cre transgenic mice for endothelial cell-lineage analyses in mice and for endothelial-cell specific gene targeting. These mice provide new insight into endothelial-mesenchymal transformation in vivo in the mammalian developing heart.
MATERIALS AND METHODS

Construction of the Tie2-Cre Transgene
The Cre expression vector pBS185 (Gibco-BRL, Gaithersburg, MD) was digested with XhoI and HindIII to excise a 2.7-kb fragment consisting of Cre cDNA and metallothionein-1 (MT-1) polyA signal sequence. The 2.7-kb fragment was blunt-ended with Klenow enzyme and ligated to the murine 2.1-kb Tie2 promoter, pg50H1-2 (Schlaeger et al., 1997) . Then, the murine Tie2 enhancer fragment extending from a NaeI site of exon 1, approximately 10 kb into the first intron and derived from pg50-2.11 (Schlaeger et al., 1997) , was ligated downstream of the MT-1 polyA signal sequence. The resulting Tie2-Cre transgene is comprised of the Tie2 promoter, Cre cDNA, MT-1 polyA signal sequence, and Tie2 intron 1 enhancer.
Production of Transgenic Mice
All procedures were approved by the Institutional Animal Care Research Advisory Committee at The University of Texas Southwestern Medical Center at Dallas. The Tie2-Cre transgene was excised from the plasmid vector backbone. Microinjection into fertilized C57BL6 ϫ SJLF 1 oocytes and other surgical procedures were performed as described (Hofmann et al., 1988) . The genotypes of all offsprings were analyzed by PCR as well as dot blots on genomic DNA from tail biopsies using Nytlan membranes (Schleicher and Schuell, Keene, NH), which was hybridized with random-prime radiolabeled Cre cDNA probe. For PCR analysis, DNAs were amplified 35 cycles (94°C for 1 min, 60°C for 1.5 min, 72°C for 2 min) in a thermal cycler. The primers were 5Ј-CGCATAACCAGTGAAACAGCATTGC-3Ј in Cre coding region and 5Ј-CCCTGTGCTCAGACAGAAATGAGA-3Ј in the Tie2 promoter region.
Detection of Transgene Expression by Reverse Transcriptase (RT)-PCR
Total RNA was extracted from different tissues including the heart, lung, kidney, liver, small intestine, large intestine, and brain from wild-type and transgenic mice using RNA STAT-60 reagents (TelTest, Friendswood, TX) . Poly(A)-rich RNA was subsequently prepared using oligo-dT cellulose columns. For RT-PCR of transgenic mRNA, first strand cDNA was synthesized with oligo(dT) 12-18 primers using Superscript II reverse transcriptase as recommended by the manufacturer (Gibco BRL, Gaithersburg, MD). Oligonucleotide primers (upstream, 5Ј-GCAATGGTGCGCCTGCTGGAAGATGG-3Ј; downstream, 5Ј-GGAGCTGGTGCAAGTGCAGGAGCC-3Ј), which flank the intron in the transgene were used to PCR amplify the transgene. Two cycle conditions were used. The first 19 cycles used the conditions of 94°C for 1 min, 68 -0.5°C/cycle for 2 min. The subsequent 15 cycles used the conditions of 94°C for 1 min, 58°C for 2 min, and 72°C for 2 min. The resulting ϳ350-bp product (as opposed to the ϳ900-bp genomic DNA-derived product) was isolated electrophoretically in 1.4% agarose and visualized by ethidium bromide staining.
LacZ Staining
Tie2-Cre transgenic mice were bred with CAG-CAT-Z transgenic mice (Araki et al., 1995) or R26R transgenic mice (Soriano, 1999) for histological analyses. The CAG-CAT-Z transgene has a choline acetyltransferase (CAT) cassette which is flanked by two loxP sites, followed by a lacZ cassette. The transgene is under control of the ubiquitous CAG promoter (Niwa et al., 1991) ; however, lacZ expression is only activated by Cre-mediated recombination. The R26R transgenic mice is made by homologous recombination of a gene trap cassette into a 5Ј intron of the ROSA26 locus, which is expressed ubiquitously and uniformly at all developmental and postnatal stages (Friedrich and Soriano, 1991) . The gene trap cassette includes a splice acceptor, neomycinresistant cassette which is flanked by two loxP sites, and a lacZ cassette (Soriano, 1999) . Similar to the CAG-CAT-Z transgenic mice, lacZ expression is only activated by Cre-mediated recombination in R26R transgenic mice. As a control, embryos of Tie2-lacZ transgenic mice were also used for lacZ staining (Schlaeger et al., 1997) . Whole-mount lacZ staining of embryos was performed as follows: First, embryos were fixed with 4% paraformaldehyde/ phosphate buffered saline (PBS) on ice for 1 h, then rinsed with buffer containing 0.2 M sodium phosphate (pH 7.3), 2 mM magnesium chloride, 0.02% NP-40, and 0.01% sodium deoxycholate (Rinse Buffer). Rinsed embryos were stained in the same buffer containing 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and 1 mg/ml X-gal (5-bromo-4-chloro-3-indoyl ␤-Dgalactopyranoside). Whole-mount stained embryos were embedded in paraffin, sectioned at 7 m, and mounted on the slides. LacZstained sections were lightly counterstained with eosin, mounted in Permount (Fisher Scientific), and photographed under an Olympus BX-50 microscope.
RESULTS
Eight independent lines of Tie2-Cre transgenic mice were generated and screened for expression by RT-PCR. RT-PCR confirmed Cre transgene expression in tissues of all of eight lines (data not shown). We analyzed each of these lines histologically by lacZ staining of Tie2-Cre transgenic mice bred with either CAG-CAT-Z transgenic mice or R26R transgenic mice. Two independent lines, which carry ϳ2 (line 155-1) and ϳ20 (line 161-8) copies of the transgene (as estimated by dot blot hybridization with radiolabeled probes), show strong ␤-galactosidase activity in virtually all blood vessels of E11.5 Tie2-Cre;CAG-CAT-Z double transgenic mouse embryos (Fig. 1) . This staining pattern is highly similar to the E11.5 Tie2-lacZ embryos (Schlaeger et al., 1997) and no background staining is observed in CAG-CAT-Z embryos. This indicates that the Tie2 promoter/ enhancer regions we used in this study faithfully drive Cre transgene expression in a pan-endothelial-specific fashion. Sections of Tie2-Cre;CAG-CAT-Z embryos confirm lacZ staining in the endocardium and endothelial cells in the aorta, umbilical arteries, and veins, as well as small blood vessels (Fig. 2) .
Interestingly, we detect strong lacZ staining in the mesenchymal cells of the AV canal and part of the outflow tract in Tie2-Cre;CAG-CAT-Z embryos (Fig. 2) . A small number of circulating cells are also positive for lacZ (Fig. 6F) . The endocardial cushion of Tie2-lacZ embryos shows no lacZ staining (Fig. 3) . To investigate lacZ staining in mesenchymal cells of the developing heart of Tie2-Cre;CAG-CAT-Z embryos further, we examined earlier time points. In E7.5 embryos, lacZ staining is observed in a subset of cells in the extra-embryonic mesodermal component of visceral yolk sac (Figs. 4A-4C ). In E8.5 embryos (when the cardiac jelly is still acellular), only a fraction of endothelial cells in the aorta and common atrial chamber show lacZ staining (Fig.  4D) ; not all of the endocardial cells are lacZ-positive. In the blood islands of E8.5 yolk sac, we detect lacZ staining in the majority of endothelial cells; however, we do not see lacZ staining in hematopoietic cells (Fig. 4H) . In E9.5 embryos, lacZ staining is observed in almost all endothelial cells and endocardial cells. This is the first stage that mesenchymal cells in the AV regions are noticeable. In addition to endocardial cells, mesenchymal cells in the AV regions also show strong lacZ staining (Fig. 5B) . The number of mesenchymal cells in the OT region is much smaller than in the AV canal in this embryonic stage. A subset of these mesenchymal cells are lacZ positive (Fig. 5C ). We also examined the omphalomesenteric artery as well as the vitelline artery, where native Tie2 receptor-expressing hematopoietic cells are located (Takakura et al., 1998) . However, we did not detect lacZ staining in the hematopoietic cells in these regions (data not shown). In E10.5 embryos, the number of mesenchymal cells in the OT region increases significantly; however, lacZ staining is only observed in the proximal or conal cushions (Fig. 5D ). LacZ staining is not observed in mesenchymal cells in the distal outflow tract and branchial arch arteries, although endothelial cells in these regions are lacZ positive (Fig. 5E) . In contrast to the OT region, almost all of mesenchymal cells in the AV canal show strong lacZ staining (Fig. 5F ). In the OT regions of E11.5 embryos, lacZ-positive mesenchymal cells are observed in the developing leaflets of pulmonary valve and aortic valve (Figs. 6A and 6C ). Mesenchymal cells in the outflow septum at the level of the conus show lacZ staining throughout the depth of the cushion. Interestingly, however, mesenchymal cells in the distal outflow tract are negative for lacZ (Figs. 6B, 6E ). We observed very weak lacZ staining primarily in the endothelial cells in Tie2-Cre; CAG-CAT-Z transgenic embryos older than E12.5 (data not shown).
DISCUSSION
Endothelial Lineage Analyses Using Tie2-Cre; CAG-CAT-Z Transgenic Mice
In Tie2-lacZ mice, the lacZ staining pattern demonstrates transcriptional activity of the Tie2 promoter/ enhancer at a given time point (Schlaeger et al., 1997 (Schlaeger et al., , 1995 . In contrast, the lacZ staining pattern of Tie2-Cre;CAG-CAT-Z double transgenic mice provides a lineage history of transcriptional activity because once Cre-mediated recombination occurs and activates lacZ expression, the transgene cannot revert back to the original allele, and the recombined lacZ transgene is inherited through the cellular lineage. Since the Tie2 promoter/enhancer drives expression of the transgene in a pan-endothelial-specific manner, Tie2-Cre;CAG-CAT-Z mice are useful for endothelial cell lineage analyses.
In addition to the strong, pan-endothelial lacZ staining in Tie2-Cre;CAG-CAT-Z mouse embryos, mesenchymal cells in the AV canal of these embryos show strong lacZ staining. This observation is consistent with observations of endocardial-mesenchymal transformation in heart explants of the chick and mouse (Camenisch et al., 2000; Nakajima et al., 1997; Runyan and Markwald, 1983; Yamamura et al., 1997) and provide further support for these previous reports in an unperturbed in vivo setting. Formation of the endocardial cushion is less well understood in the mouse heart. The lacZ staining in the AV cushion of the heart in Tie2-Cre;CAG-CAT-Z embryos suggests that mesenchymal cells in the AV cushion are of endocardial cell lineage. Lo et al. constructed a Connexin 43 (Cx43)-lacZ transgenic mouse line using the promoter region of Cx43, a member of the gap junction proteins (Lo et al., 1997) . Judging from the similarity of the lacZ expression in Cx43-lacZ transgenic mouse with the migration of cardiac neural crest cells in chick-quail chimeras, the Cx43-lacZ transgenic mouse is an in vivo mouse model for cardiac neural crest patterning (Waldo et al., 1999) . Interestingly, Cx43-lacZ transgenic mice do not show lacZ staining in the AV cushion. The absence of lacZ expression in the AV cushion of Cx43-lacZ transgenic mice and strong lacZ expression in the AV cushion in Tie2-Cre;CAG-CAT-Z transgenic mice further supports the endocardial origin of the mesenchymal cells in AV canal.
In contrast to the AV canal, only a limited number of mesenchymal cells in the OT regions, such as the outflow septum at the level of the conus and the developing valve leaflets, show lacZ staining. Experiments using chick-quail chimeras demonstrated that the mesenchymal cells in the OT regions are derived from both cardiac neural crest cells and nonneural crest cells (Waldo et al., 1998 (Waldo et al., , 1999 . The lacZ staining in the OT regions of the Tie2-Cre;CAG-CAT-Z embryos is consistent with these observations in the avian system. Cardiac neural crest cells migrate into the outflow tract and form the prongs of the aorticopulmonary septum around E9.5 in mice. In Cx43-lacZ embryos, mesenchymal cells surrounding the lumen of the aortic sac and distal outflow tract are lacZ positive at E9.5 [ Fig. 2 in (Waldo et al., 1999) ]. In Tie2-Cre;CAG-CAT-Z embryos, lacZ-positive mesenchymal cells are detected in the proximal outflow tract. However, mesenchymal cells in the distal outflow tract are lacZ-negative. In the avian system, the proximal outflow cushions fuse by a completely different mechanism from the distal outflow cushions with little contribution from extracardiac cells. The proximal outflow tract is not formed from the aorticopulmonary septation complex, but by closure of the myocardializing conal cushions (van den Hoff et al., 1999) . The clear demarkation of proximal (lacZ positive) from distal outflow cushions (lacZ negative) in Tie2-Cre;CAG-CAT-Z embryos (Figs. 6B and 6E) also supports the fact that the proximal outflow tract develops differently from the distal outflow tract. Interestingly, this demarkation coincides with the region where BMP-7 (proximal) expression is replaced by BMP-4 (distal) (Yamada et al., 1999) . The distal cardiac outflow tract is divided into aortic and pulmonary channels by the aorticopulmonary septum around E11.5. In Cx43-lacZ embryos, lacZ expression is observed in the common wall shared by aortic and pulmonary channels [ 1999)]. Conversely, in Tie2-Cre;CAG-CAT-Z E11.5 embryos, lacZ staining is observed in the endothelial cells of aortic and pulmonary channels but not in the mesenchymal cells which compose the aorticopulmonary septum.
Using Wnt1-Cre;R26R double transgenic mice, Jiang et al. reported lineage analysis of cardiac neural crest cells (Jiang et al., 2000) . The Wnt1 gene is expressed specifically in the neural plate, in the dorsal neural tube, and in the early migratory neural crest population at all axial levels. When the crest cell lineage migrates away from the neural tube, the Wnt1 expression is abolished and is not expressed at any other time or in any other place during later stages of development (Echelard et al., 1994) . LacZ staining of the Wnt1-Cre;R26R transgenic mice showed results very similar to that in Cx43-lacZ transgenic mice. In embryos older than E12.5, the distribution of lacZ-positive cells of the Wnt1-Cre;R26R transgenic mice is closer to the results from avian chimeras than the Cx43-lacZ transgenic mice. This difference can be explained by a decreased ongoing activity of the Cx43 promoter after E12.5.
Furthermore, using Pax3-Cre;R26R transgenic mice, Epstein et al. also reported lineage analysis of cardiac neural crest cells (Epstein et al., 2000) . The Pax3 gene encodes a transcription factor expressed in the dorsal neural tube which gives rise to neural crest cells (Goulding et al., 1991) . LacZ staining of Pax3-Cre;R26R transgenic mice was similar to that of Wnt1-Cre;R26R transgenic mice and Cx43-lacZ transgenic mice. Overall, these findings are precisely complementary to our present data.
Our results suggest that endocardial cells contribute to the non-crest-derived mesenchyme in the OT regions. For example, using Cx43-Cre transgenic mice and CAG-CATeGFP transgenic mice, in which green fluorescent protein acts as a Cre-dependent reporter instead of lacZ (Kawamoto et al., 2000) , we may be able to simultaneously label cardiac neural crest-derived and endothelial cell-derived structures in the OT region. In the present study, we cannot formally rule out the possibility of ectopic expression of the Tie2-Cre transgene in cell lineages unrelated to endothelial cells. However, we feel that this is unlikely, because we cannot detect lacZ staining in the endocardial cushion at any stage of Tie2-lacZ transgenic mice, whose lacZ expression is controlled by the identical promoter/enhancer region that we use for Tie2-Cre transgenic mice. The absence of lacZ staining in the endocardial cushion in Tie2-lacZ transgenic mice indicates that transgene expression driven by this promoter/enhancer shuts off upon endocardialmesenchymal transformation.
A study using gold-labeled quail endothelial cells of dorsal aorta showed that endothelial cells migrate into the subendothelial mesenchyme and express smooth muscle actins (DeRuiter et al., 1997) . To test the hypothesis that endothelial-mesenchymal transformation occurs in the aorta of the developing mouse, we examined the dorsal aorta of Tie2-Cre;CAG-CAT-Z mouse embryos and Tie2-Cre;R26R mouse embryos at various stages. No detectable lacZ staining was observed in subendothelial mesenchymal regions (data not shown), suggesting that endothelialmesenchymal transformation does not occur in this region during mouse development. However, the absence of lacZ staining in the mesenchyme of the dorsal aorta of Tie2-Cre; CAG-CAT-Z and Tie2-Cre;R26R embryos does not completely rule out the possibility of endothelial-mesenchymal transformation in the aorta in the mouse because we cannot exclude the possibility that the CAG promoter or ROSA26 allele is simply not active in the subendothelial mesenchyme of the aorta.
Circulating endothelial precursors or angioblast?
In addition to endothelial cells and endocardial cushion mesenchymal cells, we observed circulating lacZ-positive cells in Tie2-Cre;CAG-CAT-Z embryos. The nature of these cells is not yet clear. In Tie2-lacZ embryos, hematopoietic cells do not show lacZ staining (Schlaeger et al., 1995) . Hematopoiesis begins in the yolk sac at E7.5 and subsequently shifts to the fetal liver and then to the spleen and bone marrow (Johnson and Moore, 1975) . Before hepatic hematopoiesis, intraembryonic hematopoietic sites are the para-aortic splanchnopleural mesoderm (P-Sp) region and the aorta-gonad-mesonephros (Medvinsky and Dierzak, 1996) . The omphalomesenteric artery is formed from splanchnic mesodermal cells around E8.0 and migrates to the yolk sac, where the vitelline artery is formed by E9.0. The native Tie2 receptor is expressed not only in the endothelial cells of these arteries but also in the hematopoietic cells which aggregate and adhere to the endothelial cells of these arteries (Takakura et al., 1998) . However, in In the blood islands of the E8.5 yolk sac, expression of lacZ is observed in the majority of endothelial cells, but not in the hematopoietic cells. ep, ectoplacental cone; al, allantois; ao, dorsal aorta; at, common atrial chamber; bi, blood island. 
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In Vivo Endothelial Lineage Analysis Tie2-Cre;CAG-CAT-Z embryos, we did not detect lacZpositive hematopoietic cells in the blood islands of the yolk sac, in the omphalomesenteric artery, or in the vitelline artery. Interestingly, Takahashi et al. showed that bone marrow-derived endothelial cells can be recruited to form endothelial cells in blood vessels (Takahashi et al., 1999) . They subjected wild-type mice to lethal irradiation followed by bone marrow transplantation. Donor bone marrow was derived from Tie2-lacZ transgenic mice. Their results indicate that endothelial progenitor cells can be recruited from the bone marrow to the areas where neovascularization takes place. Furthermore, using human peripheral blood samples, Lin et al. reported the endothelial outgrowth potential and kinetics of bone marrow-derived hematopoietic cells (Lin et al., 2000) . These results suggest that circulating endothelial progenitor cells exist and that they are derived from bone marrow. The circulating, lacZpositive cells in Tie2-Cre;CAG-CAT-Z transgenic embryos may therefore be circulating endothelial progenitor cells. We hypothesize that the Tie2 promoter/enhancer becomes active after some hematopoietic cells differentiate into circulating endothelial progenitor cells; this may explain why hematopoietic cells in the blood island, omphalomesenteric artery, and vitelline artery do not show lacZ staining.
Endothelial Specific-Gene Targeting
Tie2-Cre transgenic mice can provide valuable information regarding the roles of molecules which may be involved with the endocardial-mesenchymal transformation in vivo (Camenisch et al., 2000) . In Tie2-Cre;CAG-CAT-Z transgenic embryos, not all of the AV cushion cells are lacZ positive but the number of lacZ positive cells seems to increase during the development (Figs. 5B, 5F , and 6D). This can be because more lacZ-positive endocardial cells participate in endocardial-mesenchymal transformation, or because the lacZ positive cushion cells proliferate. At this moment, we cannot differentiate these possibilities. Tie2-Cre transgenic mice also enable endothelial cell (endothelial cell-lineage)-specific gene targeting by the Cre/loxP system. Lethal developmental abnormalities that result from systemic disruption of the genes expressed during embryonic development frequently impede the (patho)-physiologic analyses of the roles of these gene products in adult mice. Tissue-specific gene targeting may overcome these problems and thus allow (patho)physiologic analyses of the genes in adult mice. For example, conventional targeting of endothelin-1 (Et-1), of which the main expression site is endothelial cells in adult mammals, results in developmental abnormalities and neonatal death (Kurihara et al., 1994) . We are using Tie2-Cre transgenic mice to create mice with an endothelial cell-specific disruption of the ET-1 in order to reveal the physiologic role of endothelial-endothelin-1 in adult animals (Kisanuki et al., unpublished data) .
In conclusion, we generated Tie2-Cre transgenic mice, which facilitate endothelial cell-lineage analyses and endothelial cell-specific gene targeting. LacZ staining of Tie2-Cre;CAG-CAT-Z embryos were consistent with endocardial-mesenchymal transformation in the AV canal and part of the OT regions. Importantly, these observations were made in the setting of the intact, unmanipulated embryos, not in the organ culture or transplantation chimeras. Tie2-Cre transgenic mice will be a powerful genetic model to improve the understanding of the roles of the genes expressed in endothelial cells during embryonic development as well as (patho)physiologic conditions such as atherosclerosis, cancer, and wound healing.
